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A 67 year old man with recurrent hypotensive ventric•
ular tachycardia, amiodarone-induced bradyarrhyth•
mias and severe cardiac dysfunction underwent simul•
taneous implantation of an automatic cardioverterl 
defibrillator and bipolar atrioventricular (A V) pace•
maker. The pacing electrodes were placed epicardially 
near the right atrial appendage and on the lateral right 
ventricular wall. The rate detector of the automatic de•
fibrillator was placed epicardially on the posterobasal 
Since the first report (1) in 1980 of successful automatic 
termination of life-threatening ventricular tachyarrhythmias 
by a surgically implanted device, the safety and efficacy of 
this form of treatment have been well documented, and the 
number of patients treated with the automatic implantable 
cardioverter/defibrillator (AleD, Intec Systems, Inc.) is rap•
idly growing. The implantation of this device in a patient 
already wearing a permanent pulse generator may neces•
sitate revision of the pacing leads to prevent the stimulation 
artifact from being sensed by the cardioverter/defibrillator 
and interfering with its function (2). This concern is par•
ticularly relevant when the patient wears a dual chamber 
pulse generator or a unipolar single chamber unit. The recent 
availability of a bipolar dual chamber DDD pacemaker gave 
us the opportunity to evaluate the compatibility of this new 
pacing device with the automatic implantable cardioverter/ 
defi brillator. 
Case Report 
Clinical features. A 67 year old man with a history of 
myocardial infarction (1963 and 1978) had an episode of 
out-of-hospital cardiac arrest in January 1984 for which he 
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left ventricular wall. Effective bipolar A V pacing produced 
no false counting of the heart rate by the automatic 
cardioverter/defibrillator, and ventricular tachycardia 
properly inhibited the pacemaker. Long-term follow-up 
study confirmed the safety -of this treatment. With proper 
precautions, bipolar A V pacing can be safely combined 
with an automatic cardioverter/defibrillator. 
(J Am Coli CardioI1986;7:933-7) 
underwent serial electrophysiologic studies and was sub•
sequently started on a regimen of amiodarone. His left ven•
tricular ejection fraction, measured by radionuclide angi•
ography, was 15%. In October 1984 he was readmitted to 
the hospital for another episode of syncope due to ventricular 
tachycardia and required direct current cardioversion. While 
in sinus rhythm the patient was bradycardic with heart rates 
between 35 and 50 beats/min and episodes of sinus arrest 
and junctional escape rhythm, usually associated with diz•
ziness and chest tightness radiating to both arms. Pro•
grammed stimulation induced ventricular tachycardia at a 
rate of 200 beats/min, requiring cardioversion. He was re•
ferred to our center for implantation of an automatic defi•
brillator and a permanent pacemaker. 
On examination, the patient looked chronically ill. The 
pulse rate was 48 beats/min and regular and the supine blood 
pressure was 128/60 mm Hg. Pertinent physical findings 
included a loud apical third heart sound and, on auscultation 
of the lungs, bilateral basilar rales. The 12 lead electrocar•
diogram revealed sinus bradycardia with periods of atrio•
ventricular (A V) dissociation and junctional escape rhythm, 
first degree A V block, right bundle branch block, left an•
terior fascicular block, old inferior and anterior infarctions 
and a QT interval of 540 ms. Figure 1 is a representative 
rhythm strip recorded shortly after the patient's admission 
to the hospital. 
Left ventricular and coronary angiography revealed se•
vere left ventricular dysfunction, a large anteroapical an•
eurysm and severe inferolateral hypokinesia. The proximal 
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Figure 1. Rhythm strip obtained on 
the patient's admission to the hos•
pital, showing intermittent atrioven•
tricular dissociation due to sinus 
bradyarrhythmia and a junctional es•
cape rhythm at a rate of 38 beats/min . 
Shown are (from top to bottom) leads 
II, V I and V 5. The recording speed 
is 25 mmls. 
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left anterior descending coronary artery was occluded and 
there was 95 and 30% stenosis of the mid-right coronary 
artery and proximal circumflex artery, respectively. 
Surgical procedures. The patient underwent resection 
of the anterior ventricular aneurysm, encircling endocardial 
ventriculotomy of the residual scar on the ventricular septum 
and subendocardial resection of additional scar on the lateral 
wall of the left ventricle, sequential bypass grafting of two 
branches of the right coronary artery and implantation of an 
automatic cardioverter/defibrillator and a bipolar dual cham•
ber pulse generator. 
Electrode systems. The electrode system for the car•
dioverter/defibrillator consisted of a large patch applied to 
the lateral wall of the left ventricle, two rate-counting screw•
in electrodes (Medtronic 6917 A) placed 10 mm apart on the 
posterobasalleft ventricular wall and an intravascular spring 
electrode placed at the superior vena caval-right atrial junc•
tion, introduced through the innominate vein. The electrode 
system for the pacing device consisted of two screw-in elec•
trodes (Medtronic 6917 A) placed 10 mm apart on the lateral 
wall of the right ventricle for ventricular pacing, and two 
fish-hook electrodes (Medtronic 4951) implanted 10 mm 
apart near the right atrial appendage for atrial pacing. Fig•
ures 2A and 2B illustrate the electrode configuration viewed 
on a posteroanterior chest roentgenogram. Subcutaneous 
pockets were prepared in the supraumbilical area and in the 
abdominal right upper quadrant for housing of the cardio•
verter/defibrillator and the pacemaker, respectively, and the 
electrodes of each device were tunneled transthoracically to 
the appropriate pockets. 
Electrogram amplitude measured from the epicardial rate•
counting electrodes was 21 m V, and that measured from 
the transcardiac spring-patch bipole was 11 mY. Electro•
gram amplitude measured from the ventricular pacing bipole 
was 24 m V, and that measured from the atrial pacing bipole 
was 1.6 mY. The atrial pacing threshold was 2.3 V/4.9 rnA, 
and the ventricular pacing threshold was 0.8 V/I.3 rnA. 
The pacing leads were connected to the pulse generator 
(Medtronic Symbios, model 7006), which was temporarily 
programmed to an AOO mode at a rate of 70 beats/min, a 
pulse width of 0.5 ms and an output of 5 V. Further re•
cordings obtained from the rate-sensing electrodes showed 
that atrial pacing produced no visible artifact. At the end 
of the procedure, cardioversionldefibrillation threshold mea•
surements and successful testing of the unit (AID-B, rate 
cutoff 152.5 beats/min) were performed, and the chest was 
closed. The pulse generator was programmed to the AOO 
mode until the patient awakened, and was then repro•
grammed to DDD pacing. Noninvasive, audible monitoring 
of the cardioverter/defibrillator function during AOO and 
A V sequential pacing confirmed that atrial pacing was not 
sensed by the unit and that ventricular activation was sensed 
as a single and only electrical event. 
Postoperative hemodynamic measurements during dual 
chamber pacing showed a pulmonary capillary wedge pres•
sure of less than 10 mm Hg and a cardiac index between 
2.8 and 3.5 liters/min per m2 . Because of postoperative 
respiratory complications the patient remained for 7 weeks 
under continuous cardiac monitoring during which appro•
priate A V sequential pacing was consistently verified and 
no shock was recorded or reported by the patient. 
Electropbysiologic study. Before his discharge from the 
hospital, the patient underwent another electrophysiologic 
study to measure the results of surgical treatment and to 
confirm the adequate function of the cardioverter/defibril•
lator. During the first part of the procedure the unit was 
activated but inhibited with a magnet, to avoid its triggering 
by the stimulation program. Programmed stimulation of the 
right ventricular apex, including triple extrastimulation after 
trains of ventricular paced rhythm at cycle lengths as short 
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as 400 ms, was unsuccessful in inducing sustained ventric•
ular tachycardia. Instead, several episodes of nonsustained, 
monomorphous ventricular tachycardia with a cycle length 
of 370 ms were observed, the longest one lasting 27 seconds. 
During such episodes no inappropriate impulses origmating 
Figure 2. A, Posteroanterior chest 
roentgenogram showing configura•
tion of the electrodes from the au•
tomatic cardioverter/defibrillator and 
from the dual chamber pacemaker. 
B, Artist's representation and de•
scription of the electrode system as 
seen on chest roentgenogram. B 
Atnal pacing 
bipolar electrodes 
DOD pacemaker 
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from the A V sequential pacemaker were observed. Finally, 
the patient was sedated, the magnet was removed from over 
the cardioverter/defibrillator and non sustained ventricular 
t"chycardia with a cycle length of 360 ms was induced. 
This rhythm was properly sensed by the automatic device, 
Ui' c' , <rL. 'i, d 
__ --';-_ Supenor vena cava 
spring electrode 
,~--+-+-__ ---';-_ Bipolar rate 
counting electrodes 
'-H'---t-+---- Apical patch 
electrode 
_+-_ Automatic cardloverter 
defibnllator 
936 RUFFY ET AL 
AUTOMATIC CARDIOVERSION AND CARDIAC PACING 
which delivered a synchronized shock 13.5 seconds after 
the onset of programmed stimulation, 11.5 seconds after 
the onset of ventricular tachycardia and 5.5 seconds after 
its spontaneous termination. The amiodarone blood level on 
the day of this procedure, 50 days after discontinuation of 
therapy, was 0.6 jLg/ml. 
The patient was discharged from the hospital the next 
day on a drug regimen including amiodarone, 200 mg/day. 
After a follow-up of 12 months he has experienced neither 
recurrence of ventricular tachycardia nor discharge from the 
cardioverterl defibrillator. 
Discussion 
Potential interference of the cardioverter/defibrilhitor 
by an implanted pacemaker. The rapidly growing use of 
automatic cardioversionldefibrillation for the long-term 
treatment of life-threatening ventricular arrhythmias is pre•
senting implanting physicians with several new technical 
problems that may have important clinical consequences. 
Reports already published (2) indicate that one such prob•
lem, namely, the coexisting need for long-term pacing and 
standby cardioversion/defibrillation, occurs in 5 to 10% of 
patients. Thus far, A V pacing could not be offered to those 
in need of automatic cardioversionldefibrillation because the 
unipolar pulses delivered by such pacemakers are known to 
interfere with the automatic device in two different fashions. 
The first and most common type of interference is an er•
roneous and excessive counting of the heart rate by the 
cardioverter/defibrillator, which may interpret atrial pacing 
or ventricular pacing, or both, as electrical events separate 
from ventricular activation, leading to a doubling or tripling 
of the sensed heart rate and inappropriate discharges of the 
device (3). The second form of interference occurs when 
pacing is not properly inhibited and continues during ven•
tricular tachycardia or fibrillation. This may alter the de•
tection capability of the cardioverter/defibrillator which, at 
any given time, bases its arrhythmia analysis on the largest 
intracardiac electrical signals, in this instance those origi•
nating from the pacing device. This results in failure of the 
automatic cardioverter/defibrillator to terminate the 
tachyarrhythmia. 
Precautions to be observed with combined pacemaker 
and cardioverter/defihrillator implantation. From our 
observations it appears that the recent introduction of bipolar 
A V sequential pacemakers can offer a solution to the in•
terference problem. However, precautions must be taken at 
the time of implantation to verify that even bipolar artifacts 
are not inappropriately sensed by the cardioverterl 
defibrillator. The electrodes should preferably be placed 
epicardially and as distant from each other as possible. The 
interelectrode spacing of the rate detector should be narrow, 
though one should keep in mind that the electrogram re-
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corded from it has to be at least 5 m V in amplitude to provide 
an adequate rate-counting signal. The rate detector signals 
should then be recorded and examined during atrial pacing 
to verify that no pacemaker artifact is present or large enough 
to confuse the rate counting by the cardioverter/defibrillator. 
In addition, proper counting of the heart rate by the auto•
matic cardioverter/defibrillator can be verified noninvasively 
by magnet application, which should produce a single au•
dible beep synchronized with each ventricular cycle. Ab•
sence of inappropriate pacing should be established during 
an induced episode of ventricular tachycardia. Alternatively, 
it has been suggested that the proper detection function of 
the cardioverter/defibrillator be verified by the induction of 
ventricular tachycardia and fibrillation with the unit acti•
vated and the pacemaker placed in asynchronous mode at 
maximal output (4). Because of the different characteristics 
of the intracardiac signals generated by these two rhythms, 
it is important that proper sensing be verified during induc•
tion of both rhythms. Furthermore, if the patient is known 
to experience ventricular tachycardia of variable configu•
ration, attempts should be made to verify proper detection 
of each configuration. In our patient, we decided against 
the induction of ventricular fibrillation because of his pre•
carious cardiopulmonary reserve, and because all previously 
observed episodes of tachyarrhythmia, spontaneous or in•
duced, were due to ventricular tachycardia and not fibril•
lation. We recognize, however, that this was an incomplete 
evaluation. 
During testing of the cardioverter/defibrillator befote re•
lease of the patient from the hospital, we observed its ac•
tivation by a brief run of nonsustained ventricular tachy•
cardia, with subsequent discharge duriIig sinus rhythm. This 
sequence of events has been documented by long-term car•
diac monitoring during treatment with the cardioverterl 
defibrillator (5), and is a known cause of unexpected internal 
shocks in the conscious, asymptomatic state. 
A new generation of automatic cardioverter/defibrillators 
that will have pacing capability is in the making. To the 
best of our knowledge, however, these new devices will 
provide only single chamber, ventricular pacing. Many can•
didates for automatic cardioversionldefibrillation have se•
verely impaired cardiac function and receive drugs that may 
produce chronic bradyarrhythmias; thus they are also in need 
of A V sequential pacing. Such patients will continue to pose 
the problem of pacemaker interference with the automatic 
cardioverterl defibrillator. 
We thank Margie Galkowski for her diligent secretarial assistance. 
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